New Drug Approvals

Home » Uncategorized (Page 183)

Category Archives: Uncategorized

DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

Blog Stats

  • 4,895,615 hits

Flag and hits

Flag Counter

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 37.8K other subscribers
Follow New Drug Approvals on WordPress.com

Archives

Categories

Recent Posts

Flag Counter

ORGANIC SPECTROSCOPY

Read all about Organic Spectroscopy on ORGANIC SPECTROSCOPY INTERNATIONAL 

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 37.8K other subscribers
DR ANTHONY MELVIN CRASTO Ph.D

DR ANTHONY MELVIN CRASTO Ph.D

DR ANTHONY MELVIN CRASTO, Born in Mumbai in 1964 and graduated from Mumbai University, Completed his Ph.D from ICT, 1991,Matunga, Mumbai, India, in Organic Chemistry, The thesis topic was Synthesis of Novel Pyrethroid Analogues, Currently he is working with AFRICURE PHARMA, ROW2TECH, NIPER-G, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India as ADVISOR, earlier assignment was with GLENMARK LIFE SCIENCES LTD, as CONSUlTANT, Retired from GLENMARK in Jan2022 Research Centre as Principal Scientist, Process Research (bulk actives) at Mahape, Navi Mumbai, India. Total Industry exp 32 plus yrs, Prior to joining Glenmark, he has worked with major multinationals like Hoechst Marion Roussel, now Sanofi, Searle India Ltd, now RPG lifesciences, etc. He has worked with notable scientists like Dr K Nagarajan, Dr Ralph Stapel, Prof S Seshadri, etc, He did custom synthesis for major multinationals in his career like BASF, Novartis, Sanofi, etc., He has worked in Discovery, Natural products, Bulk drugs, Generics, Intermediates, Fine chemicals, Neutraceuticals, GMP, Scaleups, etc, he is now helping millions, has 9 million plus hits on Google on all Organic chemistry websites. His friends call him Open superstar worlddrugtracker. His New Drug Approvals, Green Chemistry International, All about drugs, Eurekamoments, Organic spectroscopy international, etc in organic chemistry are some most read blogs He has hands on experience in initiation and developing novel routes for drug molecules and implementation them on commercial scale over a 32 PLUS year tenure till date Feb 2023, Around 35 plus products in his career. He has good knowledge of IPM, GMP, Regulatory aspects, he has several International patents published worldwide . He has good proficiency in Technology transfer, Spectroscopy, Stereochemistry, Synthesis, Polymorphism etc., He suffered a paralytic stroke/ Acute Transverse mylitis in Dec 2007 and is 90 %Paralysed, He is bound to a wheelchair, this seems to have injected feul in him to help chemists all around the world, he is more active than before and is pushing boundaries, He has 100 million plus hits on Google, 2.5 lakh plus connections on all networking sites, 100 Lakh plus views on dozen plus blogs, 227 countries, 7 continents, He makes himself available to all, contact him on +91 9323115463, email amcrasto@gmail.com, Twitter, @amcrasto , He lives and will die for his family, 90% paralysis cannot kill his soul., Notably he has 38 lakh plus views on New Drug Approvals Blog in 227 countries......https://newdrugapprovals.wordpress.com/ , He appreciates the help he gets from one and all, Friends, Family, Glenmark, Readers, Wellwishers, Doctors, Drug authorities, His Contacts, Physiotherapist, etc He has total of 32 International and Indian awards

Verified Services

View Full Profile →

Archives

Categories

Flag Counter

Comparing China’s And India’s Pharmaceutical Manufacturing


By Jim Zhang, Ph.D., JZMed, Inc.

The pharmaceutical markets of China and India have been experiencing such rapid growth in the past decade that they are widely recognized as two of the world’s most dynamic emerging markets. Consequently, they have attracted many drug companies around the world…………FULL ARTICLE

READ ALL AT

http://www.pharmaceuticalonline.com/doc/comparing-china-s-and-india-s-pharmaceutical-manufacturing-0001

Jim Zhang, Ph.D., is president and managing director of JZMed, Inc., a market research company specializing in research on the Chinese pharmaceutical outsourcing industry. The company also provides consulting services for pharmaceutical outsourcing in China.

 

http://www.allfordrugs.com/2013/09/11/comparing-chinas-and-indias-pharmaceutical-manufacturing/

Cheminformatics, scaffolding & tuberculosis: a work in progress


Dr. Alex M. Clark's avatarCheminformatics 2.0

tbscaff_gridOne of the projects that has been keeping me busy lately is a structure data-mining exercise intended to reveal some interesting scaffold hypotheses that can contribute to research into finding new cures for tuberculosis. The process is at an early stage, but if you’re interested in taking a look at some of the preliminary results, you can view them here.

View original post 1,145 more words

Ground breaking research identifies promising drugs for treating Parkinson’s


Cuidado con los remedios naturales que pueden producir cáncer


ateo666666's avatarLa Ciencia y sus Demonios

sn-herbal Birthwort Aristolochic Acid cancer diario de un ateo medicina tradicional china aristholochiaUno de los mayores errores actuales dentro de la medicina alternativa es la creencia popular de que los llamados “remedios naturales” a base de plantas son siempre beneficiosos y que nunca tienen ningún efecto secundario dañino.

View original post 904 more words

New effective treatment for high blood pressure? Removing tiny organ


Research Perspective in Academia and Generic Pharmaceutical Industry


Rakeshwar Bandichhor

Rakeshwar Bandichhor

Director at Dr. Reddy’s Laboratories

Research Perspective in Academia and Generic Pharmaceutical Industry

http://www.omicsonline.org/research-perspective-in-academia-and-generic-pharmaceutical-industry-2161-%200401.1000e104.php?aid=5392

Research per say is an exploratory endeavor that allows us to discover or invent not only medicine and material but how to make them in sustainable manner. In particular, research primarily involves identification of the target and its significance in terms of applicability to meet the societal needs ranging from education to commercial production of the goods.

Research Perspective in Academia and Generic Pharmaceutical Industry
Rakeshwar Bandichhor*
*Corresponding author: Dr. Rakeshwar Bandichhor
Associate Director, API, R&D
Dr. Reddy′s Laboratories, Hyderabad 500072, AP, India
E-mail: rakeshwarb@drreddys.com

 

 

 

Research Perspective in Academia and Generic Pharmaceutical Industry


Research Perspective in Academia and Generic Pharmaceutical Industry

Research Perspective in Academia and Generic Pharmaceutical Industry
Rakeshwar Bandichhor*
Associate Director, API, R&D, Dr. Reddy′s Laboratories, Hyderabad 500072, AP, India
*Corresponding author: Dr. Rakeshwar Bandichhor
Associate Director, API, R&D
Dr. Reddy′s Laboratories, Hyderabad 500072, AP, India
E-mail: rakeshwarb@drreddys.com

MEDICINAL PLANTS-moef.nic.in/downloads/public-information/Chap-9-new.pdf


moef.nic.in/downloads/public-information/Chap-9-new.pdf

moef.nic.in/downloads/public-information/Chap-9-new.pdf


moef.nic.in/downloads/public-information/Chap-9-new.pdf

Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohn’s Disease